{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:52:46Z","timestamp":1782906766789,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.7759\/cureus.111880","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:27:11Z","timestamp":1782905231000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Increased MIEN1 Copy Number With Worse Outcomes in Lung Adenocarcinoma and Cervical Cancer"],"prefix":"10.7759","author":[{"given":"Sami","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vayda","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aboujaoude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Angelakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toriana","family":"Dabkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: a population-based study","volume":"24","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Vaccarella S, Morgan E, et al.. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 2023, 24:1206-18. 10.1016\/S1470-2045(23)00444-8","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318221f701","article-title":"Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary lung adenocarcinoma classification","volume":"6","author":"Russell PA","year":"2011","unstructured":"Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2011, 6:1496-504. 10.1097\/JTO.0b013e318221f701","journal-title":"J Thorac Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-017-1497-7","article-title":"Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy","volume":"48","author":"Saito M","year":"2018","unstructured":"Saito M, Suzuki H, Kono K, Takenoshita S, Kohno T. Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy. Surg Today. 2018, 48:1-8. 10.1007\/s00595-017-1497-7","journal-title":"Surg Today"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171280","article-title":"The frequency and clinical impact of HER2 alterations in lung adenocarcinoma","volume":"12","author":"Kim EK","year":"2017","unstructured":"Kim EK, Kim KA, Lee CY, Shim HS. The frequency and clinical impact of HER2 alterations in lung adenocarcinoma. PLoS One. 2017, 12:e0171280. 10.1371\/journal.pone.0171280","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.12.019","article-title":"Prevalence and therapeutic targeting of high-level ERBB2 amplification in NSCLC","volume":"19","author":"Odintsov I","year":"2024","unstructured":"Odintsov I, Makarem M, Nishino M, et al.. Prevalence and therapeutic targeting of high-level ERBB2 amplification in NSCLC. J Thorac Oncol. 2024, 19:732-48. 10.1016\/j.jtho.2023.12.019","journal-title":"J Thorac Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050435","article-title":"Grb7, a critical mediator of EGFR\/ErbB signaling, in cancer development and as a potential therapeutic target","volume":"8","author":"Chu PY","year":"2019","unstructured":"Chu PY, Tai YL, Shen TL. Grb7, a critical mediator of EGFR\/ErbB signaling, in cancer development and as a potential therapeutic target. Cells. 2019, 8:10.3390\/cells8050435","journal-title":"Cells"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00868","article-title":"Emerging role of migration and invasion enhancer 1 (MIEN1) in cancer progression and metastasis","volume":"9","author":"Kushwaha PP","year":"2019","unstructured":"Kushwaha PP, Gupta S, Singh AK, Kumar S. Emerging role of migration and invasion enhancer 1 (MIEN1) in cancer progression and metastasis. Front Oncol. 2019, 9:868. 10.3389\/fonc.2019.00868","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104723","article-title":"HRD1 promotes non-small cell lung carcinoma metastasis by blocking autophagy-mediated MIEN1 degradation","volume":"299","author":"Zeng C","year":"2023","unstructured":"Zeng C, Guo J, Wu J, Che T, Huang X, Liu H, Lin Z. HRD1 promotes non-small cell lung carcinoma metastasis by blocking autophagy-mediated MIEN1 degradation. J Biol Chem. 2023, 299:104723. 10.1016\/j.jbc.2023.104723","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.01.163","article-title":"MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-\u03baB\/MMP-9\/VEGF pathways","volume":"472","author":"Li D","year":"2016","unstructured":"Li D, Wei Y, Wang D, Gao H, Liu K. MicroRNA-26b suppresses the metastasis of non-small cell lung cancer by targeting MIEN1 via NF-\u03baB\/MMP-9\/VEGF pathways. Biochem Biophys Res Commun. 2016, 472:465-70. 10.1016\/j.bbrc.2016.01.163","journal-title":"Biochem Biophys Res Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","unstructured":"Integrated genomic and molecular characterization of cervical cancer. Nature. 2017, 543.378-84. 10.1038\/nature21386","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1911385116","article-title":"Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy","volume":"116","author":"Zammataro L","year":"2019","unstructured":"Zammataro L, Lopez S, Bellone S, et al.. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. Proc Natl Acad Sci U S A. 2019, 116:22730-6. 10.1073\/pnas.1911385116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2017.05.013","article-title":"Grb7 is over-expressed in cervical cancer and facilitate invasion and inhibit apoptosis in cervical cancer cells","volume":"213","author":"Zhao HB","year":"2017","unstructured":"Zhao HB, Zhang XF, Jia XL, Wang HB. Grb7 is over-expressed in cervical cancer and facilitate invasion and inhibit apoptosis in cervical cancer cells. Pathol Res Pract. 2017, 213:1180-4. 10.1016\/j.prp.2017.05.013","journal-title":"Pathol Res Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2017.02.026","article-title":"Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genes","volume":"614","author":"Mauro JA","year":"2017","unstructured":"Mauro JA, Yavorski JM, Blanck G. Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genes. Gene. 2017, 614:37-48. 10.1016\/j.gene.2017.02.026","journal-title":"Gene"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2022.146673","article-title":"CNV assessments associated with outcome distinctions for adult and pediatric cancers: Loss of BRCA1 in neuroblastoma associates with a lower survival probability","volume":"836","author":"Varkhedi M","year":"2022","unstructured":"Varkhedi M, Barker VR, Eakins RA, Blanck G. CNV assessments associated with outcome distinctions for adult and pediatric cancers: Loss of BRCA1 in neuroblastoma associates with a lower survival probability. Gene. 2022, 836:146673. 10.1016\/j.gene.2022.146673","journal-title":"Gene"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00057","article-title":"Neuroblastoma and glioblastoma cases with amplified oncogenes have reduced numbers of tumor-resident adaptive immune receptor recombinations","volume":"7","author":"Dabkowski TR","year":"2023","unstructured":"Dabkowski TR, Varkhedi M, Song JJ, Gozlan EC, Blanck G. Neuroblastoma and glioblastoma cases with amplified oncogenes have reduced numbers of tumor-resident adaptive immune receptor recombinations. JCO Precis Oncol. 2023, 7:e2300057. 10.1200\/PO.23.00057","journal-title":"JCO Precis Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2025.2485873","article-title":"High GLP1R gene copy numbers associated with microsatellite instability for multiple cancers and with better survival probabilities for glioblastoma","volume":"23","author":"Thomas TM","year":"2024","unstructured":"Thomas TM, Aboujaoude MT, Barker VR, Varkhedi M, Jain R, Blanck G. High GLP1R gene copy numbers associated with microsatellite instability for multiple cancers and with better survival probabilities for glioblastoma. Cell Cycle. 2024, 23:913-21. 10.1080\/15384101.2025.2485873","journal-title":"Cell Cycle"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000599","article-title":"Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies","volume":"32","author":"Erickson BK","year":"2020","unstructured":"Erickson BK, Zeybek B, Santin AD, Fader AN. Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies. Curr Opin Obstet Gynecol. 2020, 32:57-64. 10.1097\/GCO.0000000000000599","journal-title":"Curr Opin Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/492737-association-of-increased-mien1-copy-number-with-worse-outcomes-in-lung-adenocarcinoma-and-cervical-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:27:12Z","timestamp":1782905232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/492737-association-of-increased-mien1-copy-number-with-worse-outcomes-in-lung-adenocarcinoma-and-cervical-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.111880","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}